432
Participants
Start Date
August 31, 2008
Primary Completion Date
April 30, 2009
Study Completion Date
July 31, 2009
Varenicline Tartrate
Subjects will be up-titrated during the first week of treatment in the following manner: 0.5 mg once daily for 3 days followed by 0.5 mg twice daily for 4 days, and then 1 mg twice daily for the following 11 weeks of the treatment period.
Placebo
Subjects will be up-titrated during the first week of treatment in the following manner: 0.5 mg once daily for 3 days followed by 0.5 mg twice daily for 4 days, and then 1 mg twice daily for the following 11 weeks of the treatment period.
Pfizer Investigational Site, Hamar
Pfizer Investigational Site, Hønefoss
Pfizer Investigational Site, Hafrsfjord
Pfizer Investigational Site, Rådal
Pfizer Investigational Site, Florø
Pfizer Investigational Site, Trondheim
Pfizer Investigational Site, Oslo
Pfizer Investigational Site, Gothenburg
Pfizer Investigational Site, Helsingborg
Pfizer Investigational Site, Jarfalla
Pfizer Investigational Site, Karlstad
Pfizer Investigational Site, Örebro
Pfizer Investigational Site, Södertälje
Pfizer Investigational Site, Stockholm
Pfizer Investigational Site, Sundsvall
Pfizer Investigational Site, Umeå
Lead Sponsor
Pfizer
INDUSTRY